Related Experiment Video
Updated: Jun 2, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
Published on: September 25, 2012
Biology of germ cell tumors
Yuk Ting Ma1, Michael H Cullen, Syed A Hussain
1The Cancer Centre, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK.
Abstract:
Testicular cancer has been a model for a curable malignancy. The existence of an array of potential new therapies is the result of a prodigious effort in the researching and defining of the molecular components of the cancer phenotype and the subsequent rational design of agents to target candidate pathways. A better understanding of the molecular biology of cancer may also aid in guiding the most appropriate use of existing therapies, such as conventional chemotherapy.
Insights
Testicular cancer is a highly curable malignancy. Research into its molecular biology is leading to new targeted therapies and better use of existing treatments like chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Testicular cancer serves as a key model for curable malignancies.
- Significant research efforts have focused on defining the molecular underpinnings of the cancer phenotype.
- Understanding cancer's molecular biology is crucial for therapeutic advancements.
Purpose of the Study:
- To highlight the progress in identifying molecular targets for testicular cancer therapy.
- To emphasize the role of molecular insights in designing novel anti-cancer agents.
- To discuss how molecular biology can optimize the application of current treatments.
Main Methods:
- Review of molecular profiling studies in testicular cancer.
- Analysis of rational drug design strategies targeting identified pathways.
- Evaluation of the impact of molecular understanding on chemotherapy efficacy.
Main Results:
- Identification of numerous molecular components driving the testicular cancer phenotype.
- Development of novel therapeutic agents designed to target specific molecular pathways.
- Improved comprehension of how molecular characteristics influence response to conventional chemotherapy.
Conclusions:
- Advances in molecular biology have paved the way for innovative therapies for testicular cancer.
- Targeted agents offer promising new treatment avenues.
- Molecular insights enhance the strategic use of established treatments, improving patient outcomes.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Spermatogenesis

